Poland· PL-100311100
Invirase
A saquinavir product containing saquinavirum, registered in Poland by Roche Registration GmbH. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Saquinavir is registered in 6 of 19 countries.
Countries holding a registration under ATC J05AE01 (saquinavir), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Saquinavir · ATC J05AE01
6 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Polandprice
- Spainprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Saquinavirum
- Manufacturer
- Roche Registration GmbH
- Country
- Poland (PL)
- ATC code
- J05AE01
- ATC class
- Saquinavir
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- August 16, 2026
Packs & prices · 1
- gtin05909990732517
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
470 interactions on record for saquinavir.
Graded by severity as the source publishes them — 215 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Saquinavir · interactions on record
470 records
- 215 severe
- 199 moderate
- 9 minor
- 29 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
18 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Saquinavir in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/733f58bb-4a3e-4872-bde6-a0b3734890db GET /v1/drugs/733f58bb-4a3e-4872-bde6-a0b3734890db?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "200 mg",
"packaging": "05909990732517 ¦ Rpz ¦ EU/1/96/026/001 ¦ 89437\n270 kaps.",
"substance": "Saquinavirum 200 mg",
"common_name": "Saquinavirum",
"pl_product_id": "100311100",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": "2023-08-16"
}See everything about saquinavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.